Literature DB >> 14328905

SOME PROPERTIES OF THE ENCEPHALOMYOCARDITIS, COLUMBIA SK AND MENGO VIRUSES.

J E CRAIGHEAD.   

Abstract

Keywords:  CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALOMYOCARDITIS VIRUSES; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TESTS

Mesh：

Year:  1965        PMID： 14328905     DOI： 10.3181/00379727-119-30196

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  13 in total

1.  Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report.

Authors:  F Vlaspolder; C A Kraaijeveld; R van Buuren; M Harmsen; B J Benaissa-Trouw; H Snippe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice.

Authors:  M T Barger; J E Craighead
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Growth of mouse L cells in shaken culture and mengovirus plaque formation on L cells suspended in agar.

Authors:  M W Slein; G F Logan
Journal:  Appl Microbiol       Date:  1970-11

4.  Diabetes mellitus-like syndrome in mice infected with encephalomyocarditis virus.

Authors:  J E Craighead; J Steinke
Journal:  Am J Pathol       Date:  1971-04       Impact factor: 4.307

5.  [Characterization of various representatives of the Columbia-SK virus group with fluorescent antibodies. II. Adaptation of Columbia-SK viruses to L cells].

Authors:  A Veckenstedt; M Wagner
Journal:  Arch Gesamte Virusforsch       Date:  1968

6.  Pathogenicity of the M and E variants of the encephalomyocarditis (EMC) virus. I. Myocardiotropic and neurotropic properties.

Authors:  J E Craighead
Journal:  Am J Pathol       Date:  1966-02       Impact factor: 4.307

7.  Virus-induced diabetes mellitus. V. Biological differences between the M variant and other strains of encephalomyocarditis virus.

Authors:  M E Ross; T Onodera; K Hayashi; A L Notkins
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

8.  An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.

Authors:  R P Loudon; A F Moraska; S A Huber; P Schwimmbeck; P Schultheiss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Contrasting effects of polycations on plaquing efficiency of encephalomyocarditis virus variants.

Authors:  J E Craighead; C H Layne
Journal:  J Virol       Date:  1969-01       Impact factor: 5.103

10.  Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice.

Authors:  S Frizelle; J Schwarz; S A Huber; K Leslie
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.